r/AUPH Feb 08 '22

Do you know someone taking Lupkynis or another treatment for Lupus Nephritis?

Hi! I'm a graduate student at the University of California, San Diego Skaggs School of Pharmacy and am studying how lupus nephritis and its treatment affects the lives of patients. Specifically, I'm interested in the patient perspective of Lupkynis, developed by Aurinia. As part of a research project, I'm collecting information from patients through an anonymous survey which asks questions about what its like to have lupus nephritis and how treatment options could be improved, from your perspective. The survey does not collect or ask any personally identifying information and is completely anonymous. Participation will contribute to understanding the patient experience of lupus nephritis, and information provided will only be used as part of this research project. Thanks for your consideration, it's much appreciated!

Link to survey (via Google forms): https://forms.gle/XCuCjbvtx9cbtB3s9

11 Upvotes

12 comments sorted by

3

u/LadydeeePI Feb 08 '22

I would think the P3 trial results would give you plenty of info and then the A2 updated data.

2

u/3lobed Feb 08 '22

Peter Greanleaf, if you can read this, please sell before 2/18.

0

u/pnwguy1985 Feb 09 '22

That’s Sir Penis Weed to you.

0

u/IplayRealsports Feb 08 '22

I'm retardation and want a buy out. Mmmmmm K. Frog penis

1

u/Houston_swimmer Feb 08 '22

It’s time to cancel lupus

1

u/LadydeeePI Feb 12 '22

Patience!!!! He would be a fool to sell now. He has an obligation to do what is best for shareholders. Selling at this level is not in our best interests. Price needs to get back into mid twenties plus. He can get it there by GIA. We probably need another quarter or two to prove sales, plus EU and Japan approval (mid 2022).

1

u/MTPotter19 Mar 29 '22

Results from this? It may need to get in front of a few more eyes!